Parkinson's Disease Drugs Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2022-2033

The Parkinson's Disease Drugs Market size was valued at US$ 8.37 billion in 2025 and is projected to reach US$ 16.62 billion by 2033, growing at a CAGR of 8.95% during 2026–2033. Rising prevalence of neurodegenerative disorders worldwide, growing investments in neurological drug development, increasing awareness of early disease diagnosis, expanding disease-modifying research, and continuous innovation in advanced therapeutic approaches are creating sustained growth opportunities for pharmaceutical companies.

Report Coverage

Drug Class: Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B Inhibitor, Catechol-O-Methyltransferase Inhibitors
Route of Administration: Oral, Injection, Transdermal
Distribution Channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

US$ 8.37 Bn Market size in 2025

US$ 16.62 Bn Market Size by 2033

8.95% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Chemicals and Materials

Report Code: BMIPUB00036591

Last Updated: 2026-08-06

Author

Suraj Sajeev

Manager Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Parkinson's Disease Drugs Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Parkinson's Disease Drugs Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Parkinson's Disease Drugs Market Global Analysis

6.2 Parkinson's Disease Drugs Market Revenue 2022-2033 (US$ Billion)

6.3 Parkinson's Disease Drugs Market Forecast Analysis

7. Parkinson's Disease Drugs Market Analysis – by Drug Class

7.1 Decarboxylase Inhibitors

7.1.1 Overview
7.1.2 Decarboxylase Inhibitors: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Dopamine Agonists

7.2.1 Overview
7.2.2 Dopamine Agonists: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.3 Monoamine Oxidase Type B Inhibitor

7.3.1 Overview
7.3.2 Monoamine Oxidase Type B Inhibitor: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.4 Catechol-O-Methyltransferase Inhibitors

7.4.1 Overview
7.4.2 Catechol-O-Methyltransferase Inhibitors: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Parkinson's Disease Drugs Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview
8.1.2 Oral: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Injection

8.2.1 Overview
8.2.2 Injection: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.3 Transdermal

8.3.1 Overview
8.3.2 Transdermal: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Parkinson's Disease Drugs Market Analysis – by Distribution Channels

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Retail Pharmacy

9.2.1 Overview
9.2.2 Retail Pharmacy: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.3 Online Pharmacy

9.3.1 Overview
9.3.2 Online Pharmacy: Parkinson's Disease Drugs Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Parkinson's Disease Drugs Market – Geographic Analysis

10.1 Overview

10.2 North America

10.2.1 Parkinson's Disease Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
10.2.1.1 Parkinson's Disease Drugs Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.1.1 US: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.2.1.1.2 US: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.2.1.1.3 US: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.2.1.2 Canada: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.2.1 Canada: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.2.1.2.2 Canada: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.2.1.2.3 Canada: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.2.1.3 Mexico : Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.3.1 Mexico : Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.2.1.3.2 Mexico : Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.2.1.3.3 Mexico : Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3 Europe

10.3.1 Parkinson's Disease Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
10.3.1.1 Parkinson's Disease Drugs Market – Revenue and Forecast Analysis – by Country
10.3.1.1 Germany: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.1.1 Germany: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.1.2 Germany: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.1.3 Germany: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.2 Italy: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.2.1 Italy: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.2.2 Italy: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.2.3 Italy: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.3 France: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.3.1 France: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.3.2 France: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.3.3 France: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.4 U.K.: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.4.1 U.K.: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.4.2 U.K.: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.4.3 U.K.: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.5 Spain: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.5.1 Spain: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.5.2 Spain: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.5.3 Spain: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.6 Belgium: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.6.1 Belgium: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.6.2 Belgium: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.6.3 Belgium: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.7 Netherlands: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.7.1 Netherlands: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.7.2 Netherlands: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.7.3 Netherlands: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.8 Luxembourg: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.8.1 Luxembourg: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.8.2 Luxembourg: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.8.3 Luxembourg: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.9 Norway: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.9.1 Norway: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.9.2 Norway: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.9.3 Norway: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.10 Finland: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.10.1 Finland: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.10.2 Finland: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.10.3 Finland: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.11 Denmark: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.11.1 Denmark: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.11.2 Denmark: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.11.3 Denmark: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.12 Sweden: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.12.1 Sweden: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.12.2 Sweden: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.12.3 Sweden: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.13 Switzerland: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.13.1 Switzerland: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.13.2 Switzerland: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.13.3 Switzerland: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.14 Austria: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.14.1 Austria: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.14.2 Austria: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.14.3 Austria: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.15 Greece: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.15.1 Greece: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.15.2 Greece: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.15.3 Greece: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.16 Portugal: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.16.1 Portugal: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.16.2 Portugal: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.16.3 Portugal: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.17 Russia: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.17.1 Russia: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.17.2 Russia: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.17.3 Russia: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.18 Poland: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.18.1 Poland: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.18.2 Poland: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.18.3 Poland: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.19 Romania: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.19.1 Romania: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.19.2 Romania: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.19.3 Romania: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.20 Czech Republic: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.20.1 Czech Republic: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.20.2 Czech Republic: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.20.3 Czech Republic: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.21 Ukraine: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.21.1 Ukraine: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.21.2 Ukraine: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.21.3 Ukraine: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.22 Slovakia: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.22.1 Slovakia: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.22.2 Slovakia: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.22.3 Slovakia: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.3.1.23 Bulgaria : Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.23.1 Bulgaria : Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.3.1.23.2 Bulgaria : Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.3.1.23.3 Bulgaria : Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4 Asia-Pacific

10.4.1 Parkinson's Disease Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
10.4.1.1 Parkinson's Disease Drugs Market – Revenue and Forecast Analysis – by Country
10.4.1.1 China: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.1.1 China: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.1.2 China: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.1.3 China: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.2 Japan: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.2.1 Japan: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.2.2 Japan: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.2.3 Japan: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.3 South Korea: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.3.1 South Korea: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.3.2 South Korea: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.3.3 South Korea: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.4 India: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.4.1 India: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.4.2 India: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.4.3 India: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.5 Australia: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.5.1 Australia: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.5.2 Australia: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.5.3 Australia: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.6 New Zealand: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.6.1 New Zealand: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.6.2 New Zealand: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.6.3 New Zealand: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.7 Indonesia: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.7.1 Indonesia: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.7.2 Indonesia: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.7.3 Indonesia: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.8 Malaysia: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.8.1 Malaysia: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.8.2 Malaysia: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.8.3 Malaysia: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.9 Philippines: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.9.1 Philippines: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.9.2 Philippines: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.9.3 Philippines: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.10 Singapore: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.10.1 Singapore: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.10.2 Singapore: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.10.3 Singapore: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.11 Thailand: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.11.1 Thailand: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.11.2 Thailand: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.11.3 Thailand: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.12 Vietnam: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.12.1 Vietnam: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.12.2 Vietnam: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.12.3 Vietnam: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.13 Taiwan: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.13.1 Taiwan: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.13.2 Taiwan: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.13.3 Taiwan: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.4.1.14 Bangladesh : Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.14.1 Bangladesh : Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.4.1.14.2 Bangladesh : Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.4.1.14.3 Bangladesh : Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.5 South and Central America

10.5.1 Parkinson's Disease Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
10.5.1.1 Parkinson's Disease Drugs Market – Revenue and Forecast Analysis – by Country
10.5.1.1 Brazil: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.1.1 Brazil: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.5.1.1.2 Brazil: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.5.1.1.3 Brazil: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.5.1.2 Argentina: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.2.1 Argentina: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.5.1.2.2 Argentina: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.5.1.2.3 Argentina: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.5.1.3 Chile: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.3.1 Chile: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.5.1.3.2 Chile: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.5.1.3.3 Chile: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.5.1.4 Colombia: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.4.1 Colombia: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.5.1.4.2 Colombia: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.5.1.4.3 Colombia: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.5.1.5 Peru : Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.5.1 Peru : Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.5.1.5.2 Peru : Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.5.1.5.3 Peru : Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6 Middle East and Africa

10.6.1 Parkinson's Disease Drugs Market Breakdown, by Key Country, 2026 and 2033 (%)
10.6.1.1 Parkinson's Disease Drugs Market – Revenue and Forecast Analysis – by Country
10.6.1.1 Saudi Arabia: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.1.1 Saudi Arabia: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.1.2 Saudi Arabia: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.1.3 Saudi Arabia: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.2 United Arab Emirates: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.2.1 United Arab Emirates: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.2.2 United Arab Emirates: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.2.3 United Arab Emirates: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.3 Kuwait: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.3.1 Kuwait: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.3.2 Kuwait: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.3.3 Kuwait: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.4 Bahrain: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.4.1 Bahrain: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.4.2 Bahrain: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.4.3 Bahrain: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.5 Qatar: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.5.1 Qatar: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.5.2 Qatar: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.5.3 Qatar: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.6 Oman: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.6.1 Oman: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.6.2 Oman: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.6.3 Oman: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.7 Turkiye: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.7.1 Turkiye: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.7.2 Turkiye: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.7.3 Turkiye: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.8 South Africa: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.8.1 South Africa: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.8.2 South Africa: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.8.3 South Africa: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.9 Egypt: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.9.1 Egypt: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.9.2 Egypt: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.9.3 Egypt: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.10 Nigeria: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.10.1 Nigeria: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.10.2 Nigeria: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.10.3 Nigeria: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

10.6.1.11 Algeria: Parkinson's Disease Drugs Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.11.1 Algeria: Parkinson's Disease Drugs Market Breakdown, by Drug Class
10.6.1.11.2 Algeria: Parkinson's Disease Drugs Market Breakdown, by Route of Administration
10.6.1.11.3 Algeria: Parkinson's Disease Drugs Market Breakdown, by Distribution Channels

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 AbbVie Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 F. Hoffmann-La Roche Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Novartis AG

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Amneal Pharmaceuticals

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Teva Pharmaceutical Industries Ltd.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merz Therapeutics

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 UCB S.A.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Bausch Health Companies Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Supernus Pharmaceuticals

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Sun Pharmaceutical Industries Ltd.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Access the Full P Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization